1303614-25-6

Basic information

• Product Name: Methyl6-(1H-benzo[d]iMidazol-2-yl)picolinate
• Synonyms: Methyl6-(1H-benzo[d]iMidazol-2-yl)picolinate
• CAS NO: 1303614-25-6
• Molecular Formula: C14H11N3O2
• Molecular Weight: 253.25604
• Mol File: 1303614-25-6.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 513.1±60.0 °C(Predicted)
• Appearance: /
• Density: 1.322±0.06 g/cm3(Predicted)
• PKA: 10.39±0.10(Predicted)
• CAS DataBase Reference: Methyl6-(1H-benzo[d]iMidazol-2-yl)picolinate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl6-(1H-benzo[d]iMidazol-2-yl)picolinate(1303614-25-6)
• EPA Substance Registry System: Methyl6-(1H-benzo[d]iMidazol-2-yl)picolinate(1303614-25-6)

Safety Data

• Hazardous Substances Data: 1303614-25-6(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 144493-38-9 6-(1'H-benzimidazol-2'-yl)pyridine-2-carboxylic acid 
• 5453-67-8 2,6-bis(methoxycarbonyl)pyridine 
• 7170-36-7 6-(methoxycarbonyl)pyridine-2-carboxylic acid 
• 95-54-5 1,2-diamino-benzene 
• 1038409-59-4 C₁₅H₁₅N₃O₃ 

Downstream Products

• 1303614-29-0 C₂₁H₁₆N₄O 

Relevant articles and documents

LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED THEREWITH, AND THERAPIES USING SAME

Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including autoimmune diseases, inflammatory diseases, chronic inflammatory diseases, diabetes, and infectiou

NOVEL JNK INHIBITORS

Disclosed are compounds of the formula (I) wherein X is N or CH, and Y is N or CR5. Also disclosed are methods of treating JNK and ERK mediated diseases using the compounds of formula 1.0.